This bill temporarily lowers the minimum data collection period for Medicare reimbursement of remote monitoring services to 2 days within a 30-day period and requires a report on optimizing remote monitoring payment policies.
Troy Balderson
Representative
OH-12
The "Expanding Remote Monitoring Access Act" aims to broaden access to remote monitoring services under Medicare by reducing the minimum data collection period required for reimbursement to 2 days within a 30-day period. It mandates a report to Congress with recommendations for a payment system that considers patient needs and the cost of remote monitoring, as well as analysis of staffing and potential savings. This adjustment seeks to improve patient care, lower healthcare costs, and increase care options by making remote monitoring more accessible.
This new bill, the "Expanding Remote Monitoring Access Act," is looking to shake up how Medicare handles at-home health tracking for a couple of years. For a two-year period after it's enacted, the big change is that remote monitoring services—think devices that track your blood pressure or oxygen levels from your couch—could be covered by Medicare if they collect patient data for just at least 2 days within a 30-day window. That's a pretty big shift from the current general rule requiring 16 days of data. The main goal here, as stated in SEC. 3, is to make these services more accessible and then figure out the best way to pay for them long-term.
So, why the change from 16 days to 2? Currently, unless it's for specific situations like COVID-19 (where a temporary 2-day rule was tested, as noted in SEC. 2, Finding 4), providers often have to hit that 16-day data collection mark to get paid by Medicare. The bill's findings (SEC. 2) point out this can be a hurdle, even when less monitoring is clinically A-OK. Imagine you've just had knee surgery; your doc might only need a few days of data from a sensor to see how your recovery is tracking, not a full 16. Or perhaps you're managing a chronic condition like hypertension, and a shorter, focused check-in is all that's needed initially. This bill essentially says, 'Let's try making this more flexible for two years' (SEC. 3) for all relevant patients, not just COVID cases, reflecting clinical evidence that fewer days can still mean quality care for things like sleep apnea, heart issues, and even physical therapy (SEC. 2, Finding 7).
This isn't just a 'set it and forget it' change. SEC. 3 of the bill also orders a deep dive. Within a year, the Secretary of Health and Human Services (HHS) has to deliver a report to Congress. This won't be a quick Google search; HHS needs to chat with a whole roster of folks – doctors, hospitals, patient advocates, tech companies, and even the VA, which, according to SEC. 2, Finding 2, saw a 53% drop in VA bed days with remote monitoring. The report needs to look at how this 2-day minimum trial goes, recommend smart ways to pay for remote monitoring in the future (maybe different payments for different monitoring lengths), figure out who should be looking at this data (and where), and even estimate potential savings from catching health issues earlier. Think of it as a roadmap for making remote monitoring a more permanent and effective part of Medicare.
If this bill gets rolling, who's likely to notice? First up, Medicare patients. If your doctor thinks remote monitoring is a good idea for you – whether it's 'remote physiologic monitoring,' which is about tracking your physical health data like heart rate or blood glucose (think chronic conditions), or 'remote therapeutic monitoring,' which uses devices to see how you're responding to treatment using non-physical data (like adherence to a therapy plan). Both types are covered under 'remote monitoring' as defined in SEC. 3 – this could make it easier to access. Healthcare providers get more leeway to use these tools without jumping through as many hoops for reimbursement. The bill’s findings (SEC. 2) suggest this could lead to better health outcomes and even cut down on hospital stays, which is good for patients and potentially for Medicare's budget too. The required HHS report (SEC. 3) will be key in seeing if those benefits pan out across the board and how to keep them going.